Spontaneous hypercalcemia in patients undergoing dialysis. Etiologic and therapeutic considerations

Beth M. Piraino, Raymond Rault, Arthur Greenberg, Jesus Dominguez, Rajni Wallia, Patricia Houck, Gino V. Segre, Tai Chen, Frances M. Foti, Jules B. Puschett

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Ten dialysis-treated patients with hypercalcemia (11.5 ± 0.3 mg/dl, mean ± SE) due to renal osteodystrophy were compared with 30 control dialysis-treated patients who were not hypercalcemic (9.5 ±0.1 mg/dl). The hypercalcemic patients were more disabled than the control patients. Fifty percent of the hypercalcemic patients and 37 percent of the control patients had a mineralization defect (p >0.6). In the control group, intact parathyroid hormone level was significantly higher in patients with osteitis fibrosa than in those with osteomalacia (247 ± 39 pg/ml versus 60 ± 20 pg/ml, respectively, p 2 tissue area, p

Original languageEnglish (US)
Pages (from-to)607-615
Number of pages9
JournalThe American Journal of Medicine
Volume80
Issue number4
DOIs
StatePublished - 1986
Externally publishedYes

Fingerprint

Hypercalcemia
Dialysis
Therapeutics
Chronic Kidney Disease-Mineral and Bone Disorder
Osteitis
Osteomalacia
Parathyroid Hormone
Control Groups

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Spontaneous hypercalcemia in patients undergoing dialysis. Etiologic and therapeutic considerations. / Piraino, Beth M.; Rault, Raymond; Greenberg, Arthur; Dominguez, Jesus; Wallia, Rajni; Houck, Patricia; Segre, Gino V.; Chen, Tai; Foti, Frances M.; Puschett, Jules B.

In: The American Journal of Medicine, Vol. 80, No. 4, 1986, p. 607-615.

Research output: Contribution to journalArticle

Piraino, BM, Rault, R, Greenberg, A, Dominguez, J, Wallia, R, Houck, P, Segre, GV, Chen, T, Foti, FM & Puschett, JB 1986, 'Spontaneous hypercalcemia in patients undergoing dialysis. Etiologic and therapeutic considerations', The American Journal of Medicine, vol. 80, no. 4, pp. 607-615. https://doi.org/10.1016/0002-9343(86)90815-6
Piraino, Beth M. ; Rault, Raymond ; Greenberg, Arthur ; Dominguez, Jesus ; Wallia, Rajni ; Houck, Patricia ; Segre, Gino V. ; Chen, Tai ; Foti, Frances M. ; Puschett, Jules B. / Spontaneous hypercalcemia in patients undergoing dialysis. Etiologic and therapeutic considerations. In: The American Journal of Medicine. 1986 ; Vol. 80, No. 4. pp. 607-615.
@article{2c91f1b219b543259654586e95509776,
title = "Spontaneous hypercalcemia in patients undergoing dialysis. Etiologic and therapeutic considerations",
abstract = "Ten dialysis-treated patients with hypercalcemia (11.5 ± 0.3 mg/dl, mean ± SE) due to renal osteodystrophy were compared with 30 control dialysis-treated patients who were not hypercalcemic (9.5 ±0.1 mg/dl). The hypercalcemic patients were more disabled than the control patients. Fifty percent of the hypercalcemic patients and 37 percent of the control patients had a mineralization defect (p >0.6). In the control group, intact parathyroid hormone level was significantly higher in patients with osteitis fibrosa than in those with osteomalacia (247 ± 39 pg/ml versus 60 ± 20 pg/ml, respectively, p 2 tissue area, p",
author = "Piraino, {Beth M.} and Raymond Rault and Arthur Greenberg and Jesus Dominguez and Rajni Wallia and Patricia Houck and Segre, {Gino V.} and Tai Chen and Foti, {Frances M.} and Puschett, {Jules B.}",
year = "1986",
doi = "10.1016/0002-9343(86)90815-6",
language = "English (US)",
volume = "80",
pages = "607--615",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Spontaneous hypercalcemia in patients undergoing dialysis. Etiologic and therapeutic considerations

AU - Piraino, Beth M.

AU - Rault, Raymond

AU - Greenberg, Arthur

AU - Dominguez, Jesus

AU - Wallia, Rajni

AU - Houck, Patricia

AU - Segre, Gino V.

AU - Chen, Tai

AU - Foti, Frances M.

AU - Puschett, Jules B.

PY - 1986

Y1 - 1986

N2 - Ten dialysis-treated patients with hypercalcemia (11.5 ± 0.3 mg/dl, mean ± SE) due to renal osteodystrophy were compared with 30 control dialysis-treated patients who were not hypercalcemic (9.5 ±0.1 mg/dl). The hypercalcemic patients were more disabled than the control patients. Fifty percent of the hypercalcemic patients and 37 percent of the control patients had a mineralization defect (p >0.6). In the control group, intact parathyroid hormone level was significantly higher in patients with osteitis fibrosa than in those with osteomalacia (247 ± 39 pg/ml versus 60 ± 20 pg/ml, respectively, p 2 tissue area, p

AB - Ten dialysis-treated patients with hypercalcemia (11.5 ± 0.3 mg/dl, mean ± SE) due to renal osteodystrophy were compared with 30 control dialysis-treated patients who were not hypercalcemic (9.5 ±0.1 mg/dl). The hypercalcemic patients were more disabled than the control patients. Fifty percent of the hypercalcemic patients and 37 percent of the control patients had a mineralization defect (p >0.6). In the control group, intact parathyroid hormone level was significantly higher in patients with osteitis fibrosa than in those with osteomalacia (247 ± 39 pg/ml versus 60 ± 20 pg/ml, respectively, p 2 tissue area, p

UR - http://www.scopus.com/inward/record.url?scp=0022456502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022456502&partnerID=8YFLogxK

U2 - 10.1016/0002-9343(86)90815-6

DO - 10.1016/0002-9343(86)90815-6

M3 - Article

C2 - 3963041

AN - SCOPUS:0022456502

VL - 80

SP - 607

EP - 615

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 4

ER -